Media & Press Kit

For Media Inquiries and to Arrange Interviews: Press@americankratom.org

_{Resources & Press Kit}

FDA Press Conference on 7-OH Video

Updated 8-Factor Analysis

FDA tells Federal Court it has “not yet determined if kratom is dangerous.”

FDA completes a kratom “dose finding study”

Congressman Jack Bergman: “Let’s prevent the feds from jeopardizing veteran addiction recovery”

Congressman Jack Bergman letter

Click to download file

Leading Edge Kratom Science - 2021 study

John hopkins survey study

Kratom Science Update: Evidence-Based Facts

Statement on the science of kratom products and their US regulation

Respiratory effects of oral mitragynine and oxycodone in a rodent model

School of Pharmacy, Concordia University Wisconsin Eight-Factor Analysis of Kratom

Twitter Exchange Between Former FDA Commissioner Scott Gottlieb and Former HHS Assistant Secretary for Health Brett Giroir

HHS Withdrawal Letter Dr. Giroir

Kratom

policy briefs

The FDA Bias Against Dietary Supplements and Botanicals (and Kratom)

The FDA Negative “Feedback Loop” on Kratom Disinformation?

What Is Kratom?

Kratom is a Food

Why Should States Enact the KCPA?

Is Kratom Safe?

The Human and Economic Impacts of the Kratom Industry in the United States

AMERICAN
KRATOM
ASSOCIATION

about advocacy gmp program gmp vendors science

facebook twitter instagram

Copyright 2025 AMERICAN KRATOM ASSOCIATION. All Rights Reserved.